lncRNA CASC2 Enhances ¹³¹I Sensitivity in Papillary Thyroid Cancer by Sponging miR-155

Table 1

The association between clinicopathologic features of patients and CASC2 level.

Clinicopathologic features	(%)	Relative CASC2 level		value
		Low (%)	High (%)
Total cases	46 (100.0)	25 (54.3)	21 (45.7)
Age (years)
≥55	26 (56.5)	14 (53.8)	12 (46.2)
<55	20 (43.5)	11 (55.0)	9 (45.0)
Gender
Male	28 (60.9)	15 (53.6)	13 (46.4)
Female	18 (39.1)	10 (55.6)	8 (45.4)
Pathological stage
I-II	25 (54.3)	10 (40.0)	15 (60.0)
III-IV	21 (45.7)	15 (71.4)	6 (28.6)
Tumor size (cm)
≥2.5	21 (45.7)	15 (71.4)	6 (28.6)
<2.5	25 (54.3)	10 (40.0)	15 (60.0)
Lymph node metastasis
No	26 (56.5)	10 (38.5)	16 (61.5)
Yes	20 (43.5)	15 (75.0)	5 (25.0)